RituximabCOVID-19 infection: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25200-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：464 / 464

相关论文

共 50 条

[31] Ocrelizumab/rituximabCOVID-19 infection
Reactions Weekly, 2024, 2005 (1) : 663 - 663
[32] RituximabCOVID-19 respiratory infection: 9 case reports
Reactions Weekly, 2021, 1863 (1) : 301 - 301
[33] Ocrelizumab/rituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 258 - 258
[34] Infliximab/rituximabCOVID-19 infection: 10 case reports
Reactions Weekly, 2022, 1895 (1) : 221 - 221
[35] Immunosuppressants/rituximabCOVID-19 infection: 23 case reports
Reactions Weekly, 2022, 1913 (1) : 254 - 254
[36] Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report
Reactions Weekly, 2022, 1922 (1) : 134 - 134
[37] RituximabCOVID-19
Reactions Weekly, 2024, 2010 (1) : 351 - 351
[38] RituximabCOVID-19: 12 case reports
Reactions Weekly, 2023, 1940 (1) : 369 - 369
[39] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2021, 1843 (1) : 318 - 318
[40] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 494 - 494

← 1 2 3 4 5 →